213 related articles for article (PubMed ID: 24243883)
1. Vaccine research for gonococcal infections: where are we?
Jerse AE; Deal CD
Sex Transm Infect; 2013 Dec; 89 Suppl 4():iv63-8. PubMed ID: 24243883
[TBL] [Abstract][Full Text] [Related]
2. Vaccines against gonorrhea: current status and future challenges.
Jerse AE; Bash MC; Russell MW
Vaccine; 2014 Mar; 32(14):1579-87. PubMed ID: 24016806
[TBL] [Abstract][Full Text] [Related]
3. Diversion of the immune response to Neisseria gonorrhoeae from Th17 to Th1/Th2 by treatment with anti-transforming growth factor β antibody generates immunological memory and protective immunity.
Liu Y; Russell MW
mBio; 2011; 2(3):e00095-11. PubMed ID: 21610119
[TBL] [Abstract][Full Text] [Related]
4. Progress Toward a Gonococcal Vaccine: The Way Forward.
Russell MW; Jerse AE; Gray-Owen SD
Front Immunol; 2019; 10():2417. PubMed ID: 31681305
[TBL] [Abstract][Full Text] [Related]
5. Is gonococcal disease preventable? The importance of understanding immunity and pathogenesis in vaccine development.
Edwards JL; Jennings MP; Apicella MA; Seib KL
Crit Rev Microbiol; 2016 Nov; 42(6):928-41. PubMed ID: 26805040
[TBL] [Abstract][Full Text] [Related]
6. Neisseria gonorrhoeae: Drug Resistance, Mouse Models, and Vaccine Development.
Rice PA; Shafer WM; Ram S; Jerse AE
Annu Rev Microbiol; 2017 Sep; 71():665-686. PubMed ID: 28886683
[TBL] [Abstract][Full Text] [Related]
7. Neisseria gonorrhoeae vaccine development: hope on the horizon?
Edwards JL; Jennings MP; Seib KL
Curr Opin Infect Dis; 2018 Jun; 31(3):246-250. PubMed ID: 29601324
[TBL] [Abstract][Full Text] [Related]
8. Biological feasibility and importance of a gonorrhea vaccine for global public health.
Vincent LR; Jerse AE
Vaccine; 2019 Nov; 37(50):7419-7426. PubMed ID: 29680200
[TBL] [Abstract][Full Text] [Related]
9. Preclinical Efficacy of a Lipooligosaccharide Peptide Mimic Candidate Gonococcal Vaccine.
Gulati S; Pennington MW; Czerwinski A; Carter D; Zheng B; Nowak NA; DeOliveira RB; Shaughnessy J; Reed GW; Ram S; Rice PA
mBio; 2019 Nov; 10(6):. PubMed ID: 31690678
[TBL] [Abstract][Full Text] [Related]
10. Immunization against a saccharide epitope accelerates clearance of experimental gonococcal infection.
Gulati S; Zheng B; Reed GW; Su X; Cox AD; St Michael F; Stupak J; Lewis LA; Ram S; Rice PA
PLoS Pathog; 2013; 9(8):e1003559. PubMed ID: 24009500
[TBL] [Abstract][Full Text] [Related]
11. Experimental vaccine induces Th1-driven immune responses and resistance to Neisseria gonorrhoeae infection in a murine model.
Liu Y; Hammer LA; Liu W; Hobbs MM; Zielke RA; Sikora AE; Jerse AE; Egilmez NK; Russell MW
Mucosal Immunol; 2017 Nov; 10(6):1594-1608. PubMed ID: 28272393
[TBL] [Abstract][Full Text] [Related]
12. Advancing vaccine development for gonorrhoea and the Global STI Vaccine Roadmap.
Gottlieb SL; Jerse AE; Delany-Moretlwe S; Deal C; Giersing BK
Sex Health; 2019 Sep; 16(5):426-432. PubMed ID: 31476278
[TBL] [Abstract][Full Text] [Related]
13. Common heat stable protective antigen in gonococci.
Ito JI; Corbeil LB; Wunderlich AC; McCutchan JA; Braude AI
Trans Assoc Am Physicians; 1979; 92():160-8. PubMed ID: 95067
[TBL] [Abstract][Full Text] [Related]
14. Current and future treatment options for gonorrhoea.
Ison CA; Deal C; Unemo M
Sex Transm Infect; 2013 Dec; 89 Suppl 4():iv52-6. PubMed ID: 24106339
[TBL] [Abstract][Full Text] [Related]
15. Problems posed by potential gonococcal vaccines viewed from the vantage point of a control agency.
Robbins JB
Br J Vener Dis; 1977 Jun; 53(3):170-2. PubMed ID: 406011
[TBL] [Abstract][Full Text] [Related]
16. Murine host response to Neisseria gonorrhoeae upper genital tract infection reveals a common transcriptional signature, plus distinct inflammatory responses that vary between reproductive cycle phases.
Francis IP; Islam EA; Gower AC; Shaik-Dasthagirisaheb YB; Gray-Owen SD; Wetzler LM
BMC Genomics; 2018 Aug; 19(1):627. PubMed ID: 30134832
[TBL] [Abstract][Full Text] [Related]
17. Immune responses to
Belcher T; Rollier CS; Dold C; Ross JDC; MacLennan CA
Front Immunol; 2023; 14():1248613. PubMed ID: 37662926
[No Abstract] [Full Text] [Related]
18. [Protective properties of gonococcal vaccines].
Ovchinnikov NM; Timchenko GF
Vestn Dermatol Venerol; 1976 Dec; (12):28-32. PubMed ID: 828819
[No Abstract] [Full Text] [Related]
19. Biology of the Gonococcus: Disease and Pathogenesis.
Shaughnessy J; Ram S; Rice PA
Methods Mol Biol; 2019; 1997():1-27. PubMed ID: 31119614
[TBL] [Abstract][Full Text] [Related]
20. Development of a gonorrhoea vaccine: prospects, strategies and tactics.
Gotschlich EC
Bull World Health Organ; 1984; 62(5):671-80. PubMed ID: 6150769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
